msocoMD Profile Banner
Marc Soco, MD Profile
Marc Soco, MD

@msocoMD

Followers
2K
Following
13K
Media
332
Statuses
2K

Nephrologist 🇵🇭 • Internist • Flozinator • GN & Transplant • @uppghnephrology Alumni • @GlomCon Fellow 2023-2024 • @Neph_Sim 2021

Cebu, Philippines
Joined December 2020
Don't wanna be here? Send us removal request.
@msocoMD
Marc Soco, MD
4 years
Kidney injury occuring in liver failure is a historical scenario imbued w/in the parlance of medicine for centuries. In this article, I try to discuss HRS— its current concepts & challenges. Thank you @Nephro_Sparks @DearbhlaKelly4 for helping me write this article!
@RenalFellowNtwk
Renal Fellow Network
4 years
Hepatorenal Syndrome: Current Concepts and Challenges by @msocoMD
9
5
70
@kidney_boy
Joel M. Topf, MD FACP
9 days
Freely Filtered dives into ACHIEVE with Mike Walsh. This was a great episode. Also with show notes, chapters, and key images (if your podcast client supports it) https://t.co/3DGoiJexLb
0
7
17
@kidney_boy
Joel M. Topf, MD FACP
1 year
I fell in love with twitter because it was the first time we had a worldwide community that could get together and nerd out about nephrology.
8
18
234
@kidney_boy
Joel M. Topf, MD FACP
16 days
It’s 2025 and we’re still dosing drugs like it’s 1976. The saga of Cockcroft–Gault, FDA inertia, and the slow evolution of renal dosing equations. 🧮 https://t.co/mrhjDtpwzX
4
43
144
@NephJC
Nephrology Journal Club
29 days
Check at the VA for our discussion of protein diet strategies by @msocoMD . Is restricting protein in CKD and pushing protein in ESRD #TWDFNR? https://t.co/PE9Jjg233Y
Tweet card summary image
nephjc.com
We like protein, or do we? Low protein, high protein, supplements…what’s a nephrologist to do?
0
8
13
@NephJC
Nephrology Journal Club
2 months
It's that time of year again 🍂🍂🍂 The #NephJC Fall pledge drive. Plese give if you are able to support our decades long mission of #FOAMed for all. #NephTwitter #MedTwitter
Tweet card summary image
nephjc.com
Help keep NephJC a vital, original, and unbiased source of medical education.
0
10
22
@NephJC
Nephrology Journal Club
3 months
It's finally here!! #NephJC summer book club 📚 Everything is Tuberculosis by @johngreen 8/19/25 @ 9pm EST, only on #BlueSky Come for the discussion, stay for stories. https://t.co/8RxScWrPkD
Tweet card summary image
nephjc.com
The summer book club started in 2015 , with one of the best books we have done in book club, Atul Gawande's Being Mortal . I think it should be required reading for all physicians. So now, in 2025,...
0
6
24
@NephJC
Nephrology Journal Club
4 months
1/10 Last #NephJC we discussed the combination therapy of empagliflozin and finerenone 💊 #TenPostNephJC 🌵From a therapeutic dessert to a flood of options in DKD - what is the best timing to keep the kidneys afloat
2
14
52
@NephJC
Nephrology Journal Club
4 months
With unshakable CONFIDENCE, finerenone and empagliflozin waltz into diabetic kidney disease - turning 'maybe someday' into 'why not today?' ✍️#NephJC summary by @sejalplakhani and @meyyappannephro ⏰🦋Chat happening on July 8, 9 pm EST https://t.co/oyHojbj3f1
Tweet card summary image
nephjc.com
This week, we will discuss how the CONFIDENCE trial gets nephrology closer to the magic CKD polypill of CKD.
0
28
45
@NephJC
Nephrology Journal Club
4 months
The #NephJC editorial team knows that plenty of papers deserve attention between our bi-monthly, full-length discussions ✨Enter #NephJCShorts - quick hits with a critical eye 🦅 on high-impact reads https://t.co/qcyGMMdlEc
Tweet card summary image
nephjc.com
In just over a decade of critical appraisal on NephJC, we have done several experiments. Some of them have worked out phenomenally well, such as the Freely Filtered podcast. Others were not ready for...
0
9
32
@msocoMD
Marc Soco, MD
5 months
When your team works this hard, coaching feels easy. Mighty proud of my residents for winning this year’s Nephrology Quiz Bowl 🏆🫘
0
0
5
@msocoMD
Marc Soco, MD
5 months
Island life perk: when a quick escape means the beach is just down the road 🌊🌴
1
0
12
@NephroSeeker
Cristina Popa 🦋
5 months
16/ Glad I’ve bumped into new and (hopefully) future #nephjc interns at #era25
1
1
7
@edgarvlermamd
Edgar V. Lerma 🇵🇭
6 months
SGLT2 inhibitor (SGLT2i) Cold 🥶 Map: Indications for SGLT2i in CKD/ Albuminuria/ Type 2 Diabetes (T2D)/ Heart Failure (HFrEF, HFmrEF, HFpEF) from @ISNkidneycare @goKDIGO @RPANephrology @ASPCardio #Nephpearls #Cardiorenal 👉 https://t.co/nZoohDs7nk
1
43
110
@Bishop_Dempsey
Bishop Paul Dempsey
7 months
A man of #humility, #hope & humour who lived a life of #service to the Church & the poor to the very last moment. Thank you @Pontifex Rest in peace 🙏 @dublindiocese @IrishCathNews @CatholicBishops
1
7
77
@Nephronline
Nephrology News & Issues
7 months
Anna Gaddy, MD, #renalphysisian and nondirected kidney donor: "It's pretty easy. You just call and they take care of everything. I'm really happy I did it." #RPA2025 @RPANephrology
1
15
46
@edgarvlermamd
Edgar V. Lerma 🇵🇭
9 months
Looking forward to this “An Evidence-Based Review of the Management of Acute (In-patient) Hypertension” #Nephpearls 🗓️ February 25, 2025 (Tuesday) ⏰ 9:00 AM 📍 UP-PGH Science Hall 🇵🇭 You may join virtually via Zoom 🎧 Meeting ID: 96854707315 Meeting Passcode: IMGR2025
1
24
83
@AKronbichler
Andreas Kronbichler
9 months
SGLT2i are highly effective drugs to prevent progression of CKD. However, several populations at risk (also to have CV events) are excluded from trials; also now that combination therapies are tested. A summary of my talk on SGLT2i and autoimmunity: https://t.co/1X28q2EcNx
5
50
134
@Lupusreference
Laurent ARNAUD
9 months
🚨 The #REGENCY phase 3 trial of #obinutuzumab in #Lupus #nephritis has just been published in the NEJM!!! DOWNLOAD LINK: https://t.co/z6C0KElEls
8
109
292